Probiotics for Inflammatory Bowel Diseases
Author Information
Author(s): Santos Emanuelle Natalee, Magalhães-Guedes Karina Teixeira, Borges Fernando Elias de Melo, Ferreira Danton Diego, da Silva Daniele Ferreira, Conceição Pietro Carlos Gonçalves, Lima Ana Katerine de Carvalho, Cardoso Lucas Guimarães, Umsza-Guez Marcelo Andrés, Ramos Cíntia Lacerda
Primary Institution: Federal University of Vale of Jequitinhonha and Mucuri (UFVJM)
Hypothesis
Can probiotic microorganisms improve the treatment of inflammatory bowel diseases (IBD)?
Conclusion
Probiotics and smart probiotics could represent the future of nutritional medicine in IBD care, allowing patients to be treated in a more natural, safe, effective, and nutritious way.
Supporting Evidence
- Probiotics have shown promising effects on consumers’ quality of life.
- Probiotic microorganisms are not part of the standard treatment protocol for IBD but are effective alternatives.
- Genetically engineered probiotics or smart probiotics are a promising treatment for IBD.
- Probiotics can improve dysbiosis and enhance gut health.
- Clinical trials have demonstrated the potential of probiotics in managing IBD symptoms.
Takeaway
Probiotics are good bacteria that can help people with gut problems like inflammatory bowel disease, making them feel better and healthier.
Methodology
This study conducted a literature review on the effects of probiotic and smart probiotic ingestion on IBD, analyzing available literature using boxplot diagrams.
Limitations
Clinical trials standardizing dosage and strains of probiotics are still necessary.
Participant Demographics
The study primarily discusses findings from various articles, including those involving young individuals affected by IBD.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website